Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273
Deborah Steensels, Noëlla Pierlet, Joris Penders, Dieter Mesotten, Line Heylen
Abstract
This study compares the immune responses to the BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) COVID-19 vaccines in health care workers in Belgium.
Topics & Concepts
MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Antibody responseCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakVaccinationVirologyMessenger RNAAntibodyImmunologyInternal medicineGeneticsGeneDiseaseBiologyOutbreakInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchViral Infections and Immunology ResearchAnimal Virus Infections Studies